The search for new therapies for human cytomegalovirus infections.
about
Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interfaceEfficacy and Mechanism of Action of Low Dose Emetine against Human CytomegalovirusA cutting-edge view on the current state of antiviral drug development.Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.The biology of cytomegalovirus drug resistanceArtemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.Association between human cytomegalovirus and onset of epilepsy.Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.Xenotransplantation and porcine cytomegalovirus.The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.Frequent pUL27 Variations in HIV-Infected Patients.17-allylamino-17-(demethoxy)geldanamycin (17-AAG) is a potent and effective inhibitor of human cytomegalovirus replication in primary fibroblast cells.USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression.New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.
P2860
Q28533839-F7CCA043-D7D8-4416-9317-5FAF8BD7AE14Q28552095-85B12B7C-8830-42A7-86EA-1153301249B0Q34036018-7A45D3B3-8E29-401E-AD36-71562F1F71E4Q34263026-D8BCFFE6-A72A-4DB7-8F62-F059F45FB42BQ34908895-83E10F52-7995-4006-9C87-50A588B0BACAQ35086196-FF161B1E-FFC0-49F9-A438-A92E9D5EDE01Q35596269-A9808FF7-F0D7-41FD-9215-D2DB9D1B6F34Q35684511-67157F45-4C84-40D3-8963-0E73A3EC9E8CQ36086432-C8CC20B8-4814-419D-8D54-0E40175220BDQ36275767-6BF9C6CA-FD05-4830-A7E8-A2C76394D141Q36492780-C0F24600-CF81-4EC6-B1BD-EBE9583B5664Q36969798-FDFAD425-817A-4558-B5C9-9C0961B050AFQ37951633-24F31082-8FB3-45EC-B4D4-287FF6C92041Q38067694-DD2AD96C-A7A1-4B64-8883-76F6BBA16533Q38588603-4AA171D4-7263-4020-84F1-4B719688A4B2Q38962962-E4DEE560-2437-4B3F-A3D1-79ADCF6B40CAQ40086009-D985E630-1F28-4B34-A32B-EDE3F917CFEEQ40245936-4B7EA7CC-DCC1-4EAC-AC80-633B5935F092Q42717415-B40DC325-E30F-4522-B20F-2015A505B529Q51730547-C5355E70-2CD9-43CD-8C10-28C20078BB1FQ52652637-CD08D558-021F-46D3-A9FC-4AB919620F0AQ52691329-0DC4A773-9081-467A-A037-BBD9FD1B4039
P2860
The search for new therapies for human cytomegalovirus infections.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The search for new therapies for human cytomegalovirus infections.
@en
The search for new therapies for human cytomegalovirus infections.
@nl
type
label
The search for new therapies for human cytomegalovirus infections.
@en
The search for new therapies for human cytomegalovirus infections.
@nl
prefLabel
The search for new therapies for human cytomegalovirus infections.
@en
The search for new therapies for human cytomegalovirus infections.
@nl
P2860
P1433
P1476
The search for new therapies for human cytomegalovirus infections
@en
P2093
Earl R Kern
P2860
P304
P356
10.1016/J.VIRUSRES.2010.11.004
P577
2010-11-21T00:00:00Z